164 related articles for article (PubMed ID: 25498536)
21. Effects of risperidone on behavioral and psychological symptoms associated with dementia in clinical practice.
Kurz A; Schwalen S S; Schmitt A
Int Psychogeriatr; 2005 Dec; 17(4):605-16. PubMed ID: 16185378
[TBL] [Abstract][Full Text] [Related]
22. Comparative efficacy of risperidone versus haloperidol on behavioural and psychological symptoms of dementia.
Suh GH; Greenspan AJ; Choi SK
Int J Geriatr Psychiatry; 2006 Jul; 21(7):654-60. PubMed ID: 16821257
[TBL] [Abstract][Full Text] [Related]
23. Galantamine versus risperidone treatment of neuropsychiatric symptoms in patients with probable dementia: an open randomized trial.
Freund-Levi Y; Jedenius E; Tysen-Bäckström AC; Lärksäter M; Wahlund LO; Eriksdotter M
Am J Geriatr Psychiatry; 2014 Apr; 22(4):341-8. PubMed ID: 24035407
[TBL] [Abstract][Full Text] [Related]
24. Introduction: the clinical impact of agitation in various psychiatric disorders: management consensus and controversies.
Mintzer JE
J Clin Psychiatry; 2006; 67 Suppl 10():3-5. PubMed ID: 16965189
[No Abstract] [Full Text] [Related]
25. Dose-dependent effect of risperidone treatment in a case of 22q13.3 deletion syndrome.
Pasini A; D'Agati E; Casarelli L; Curatolo P
Brain Dev; 2010 May; 32(5):425-7. PubMed ID: 19428206
[TBL] [Abstract][Full Text] [Related]
26. Risperidone and dementia-related aggression: new indication. A last resort, no better than haloperidol.
Prescrire Int; 2009 Dec; 18(104):248. PubMed ID: 20025088
[TBL] [Abstract][Full Text] [Related]
27. Discontinuation of risperidone in Alzheimer's disease.
Ling SM; Bonner AF; McMullen TL
N Engl J Med; 2013 Jan; 368(2):187. PubMed ID: 23301740
[No Abstract] [Full Text] [Related]
28. Discontinuation of risperidone in Alzheimer's disease.
Power GA
N Engl J Med; 2013 Jan; 368(2):186-7. PubMed ID: 23301739
[No Abstract] [Full Text] [Related]
29. Discontinuation of risperidone in Alzheimer's disease.
Gnjidic D; Hilmer SN
N Engl J Med; 2013 Jan; 368(2):186. PubMed ID: 23301738
[No Abstract] [Full Text] [Related]
30. Discontinuation of risperidone in Alzheimer's disease.
Devanand DP; Schultz SK; Sultzer DL
N Engl J Med; 2013 Jan; 368(2):187-8. PubMed ID: 23301737
[No Abstract] [Full Text] [Related]
31. Pharmacologic approach to management of agitation associated with dementia.
Kunik ME; Yudofsky SC; Silver JM; Hales RE
J Clin Psychiatry; 1994 Feb; 55 Suppl():13-7. PubMed ID: 7915710
[TBL] [Abstract][Full Text] [Related]
32. Liquid risperidone in the treatment of psychotic agitation.
Tsai C; Puzantian T
CNS Drugs; 2002; 16(11):777; author reply 778. PubMed ID: 12383033
[No Abstract] [Full Text] [Related]
33. [Longterm treatment with Risperidone in Alzheimer's disease? No justification for more "drug deaths" in nursing homes!].
Förstl H
Dtsch Med Wochenschr; 2013 Jan; 138(1-2):16. PubMed ID: 23250689
[No Abstract] [Full Text] [Related]
34. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia.
Declercq T; Petrovic M; Azermai M; Vander Stichele R; De Sutter AI; van Driel ML; Christiaens T
Cochrane Database Syst Rev; 2013 Mar; (3):CD007726. PubMed ID: 23543555
[TBL] [Abstract][Full Text] [Related]
35. Atypical antipsychotic agents ineffective for AD.
Duke Med Health News; 2007 Jan; 13(1):8. PubMed ID: 17299888
[No Abstract] [Full Text] [Related]
36. A randomized, double-blind, crossover comparison of risperidone and haloperidol in Korean dementia patients with behavioral disturbances.
Suh GH; Son HG; Ju YS; Jcho KH; Yeon BK; Shin YM; Kee BS; Choi SK
Am J Geriatr Psychiatry; 2004; 12(5):509-16. PubMed ID: 15353389
[TBL] [Abstract][Full Text] [Related]
37. Beware of over-interpreting negative trials.
Scahill L; Aman MG; McCracken JT; McDougle CJ; Vitiello B
J Autism Dev Disord; 2008 Oct; 38(9):1609-10. PubMed ID: 18594960
[No Abstract] [Full Text] [Related]
38. Atypical antipsychotics for the treatment of dementia-related behaviors: an update.
Daiello LA
Med Health R I; 2007 Jun; 90(6):191-4. PubMed ID: 17633594
[TBL] [Abstract][Full Text] [Related]
39. Antipsychotics to Treat Agitation or Psychosis in Patients With Dementia.
Yohanna D; Cifu AS
JAMA; 2017 Sep; 318(11):1057-1058. PubMed ID: 28975291
[No Abstract] [Full Text] [Related]
40. Neuroleptics for behavioral symptoms of dementia.
Reynolds PL; Strayer SM
J Fam Pract; 2000 Jan; 49(1):78-9. PubMed ID: 10678345
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
